The Procter & Gamble Company (NYSE:PG) Shares Sold by Abacus Wealth Partners LLC

Abacus Wealth Partners LLC trimmed its position in shares of The Procter & Gamble Company (NYSE:PG) by 11.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,706 shares of the company’s stock after selling 480 shares during the period. Abacus Wealth Partners LLC’s holdings in Procter & Gamble were worth $642,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble during the second quarter worth $29,000. Transcendent Capital Group LLC purchased a new stake in shares of Procter & Gamble during the fourth quarter worth $31,000. Ruedi Wealth Management Inc. increased its holdings in Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after buying an additional 77 shares during the last quarter. Finally, POM Investment Strategies LLC purchased a new position in Procter & Gamble in the second quarter valued at $34,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 1.1 %

Shares of PG stock opened at $170.06 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The stock has a 50-day simple moving average of $171.15 and a 200 day simple moving average of $166.43. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $177.94. The stock has a market capitalization of $401.37 billion, a P/E ratio of 27.79, a P/E/G ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same quarter in the prior year, the company earned $1.37 earnings per share. The firm’s revenue was down .1% on a year-over-year basis. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.37%. Procter & Gamble’s payout ratio is 65.85%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. BNP Paribas assumed coverage on Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 target price on the stock. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research note on Thursday, August 29th. Evercore ISI upped their price objective on shares of Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Nine analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $175.89.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock valued at $65,140,718 in the last ninety days. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.